Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy
Thématique(s) / pathologie(s)
- Atrophie Multi-Systématisée (AMS)
Objectifs
Informations disponibles sur : Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON) - Full Text View - ClinicalTrials.gov
Promoteur
Ionis Pharmaceuticals
Statut
Recrutement clos
